Orphan designation: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide (ivacaftor), Treatment of cystic fibrosis

2018 ◽  
Author(s):  
Sign in / Sign up

Export Citation Format

Share Document